Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
McKinney, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
McKinney, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Temple, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Temple, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Burlington, VT
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Alexandria, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Alexandria, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chesapeake, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fairfax, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fairfax, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fairfax, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fairfax, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Hampton, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hampton, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Manassas, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Manassas, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Mechanicsville, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mechanicsville, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Norfolk, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Richmond, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Richmond, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Richmond, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Silverdale, WA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Silverdale, WA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bluefield, WV
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bluefield, WV
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Milwaukee, WI
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
mi
from
Caguas,
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
mi
from
Caguas,
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oxon Hill, MD
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oxon Hill, MD
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Saint Peters, MO
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Edinburg, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Edinburg, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Washington,
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bronx, NY
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Role of Nox2 in CNI-induced Renal Fibrosis
The Role of Nox2 in CNI-Induced Renal Fibrosis
Status: Enrolling
Updated:  12/31/1969
Wisconsin Institute for Medical Research (WIMR)
mi
from
Madison, WI
Role of Nox2 in CNI-induced Renal Fibrosis
The Role of Nox2 in CNI-Induced Renal Fibrosis
Status: Enrolling
Updated: 12/31/1969
Wisconsin Institute for Medical Research (WIMR)
mi
from
Madison, WI
Click here to add this to my saved trials
Role of Nox2 in CNI-induced Renal Fibrosis
The Role of Nox2 in CNI-Induced Renal Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Role of Nox2 in CNI-induced Renal Fibrosis
The Role of Nox2 in CNI-Induced Renal Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Genetic Predictors of Renal Dysfunction Following Heart Transplantation
Pharmacogenomics of Calcineurin Inhibitor Nephrotoxicity in Cardiac Transplantation
Status: Enrolling
Updated:  12/31/1969
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Genetic Predictors of Renal Dysfunction Following Heart Transplantation
Pharmacogenomics of Calcineurin Inhibitor Nephrotoxicity in Cardiac Transplantation
Status: Enrolling
Updated: 12/31/1969
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Click here to add this to my saved trials
Outcome of BCF Access in Hemodialysis Patients
A Clinical and Computational Study to Improve Brachiocephalic Fistula (BCF) Outcomes
Status: Enrolling
Updated:  12/31/1969
University of Chicago Medical Center
mi
from
Chicago, IL
Outcome of BCF Access in Hemodialysis Patients
A Clinical and Computational Study to Improve Brachiocephalic Fistula (BCF) Outcomes
Status: Enrolling
Updated: 12/31/1969
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Adipose Tissue Function After Pancreas Transplantation
A Pilot Study to Identify the Differences in Adipose Tissue Function After Restoring Normal Glycemic Control Following Pancreas Transplantation
Status: Enrolling
Updated:  12/31/1969
The University of Texas Medical Branch (UTMB)
mi
from
Galveston, TX
Adipose Tissue Function After Pancreas Transplantation
A Pilot Study to Identify the Differences in Adipose Tissue Function After Restoring Normal Glycemic Control Following Pancreas Transplantation
Status: Enrolling
Updated: 12/31/1969
The University of Texas Medical Branch (UTMB)
mi
from
Galveston, TX
Click here to add this to my saved trials
Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease
The Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease (in the Grant Entitled: Endothelial Dysfunction in the Pathogenesis of Sickle Cell Nephropathy)
Status: Enrolling
Updated:  12/31/1969
UNC School of Medicine Clinical&Translational Research Ctr
mi
from
Chapel Hill, NC
Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease
The Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease (in the Grant Entitled: Endothelial Dysfunction in the Pathogenesis of Sickle Cell Nephropathy)
Status: Enrolling
Updated: 12/31/1969
UNC School of Medicine Clinical&Translational Research Ctr
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Huntsville, AL
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tempe, AZ
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Alhambra, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Alhambra, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chula Vista, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Inglewood, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Inglewood, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
La Mesa, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
La Mesa, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
La Palma, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
La Palma, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Northridge, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Northridge, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Paramount, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Paramount, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Riverside, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Riverside, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Roseville, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Roseville, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Dimas, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Dimas, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Whittier, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Whittier, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Hialeah, FL
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Miami, FL
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Miami, FL
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials